Abstract
Most commonly used anticancer drugs exert their effects mainly by causing DNA damage. The enhancement in DNA damage response (DDR) is considered a key mechanism that enables cancer cells to survive through eliminating the damaged DNA lesions and thereby developing resistance to DNA-damaging agents. This chapter describes the four experimental approaches for studying DDR and genotoxic drug resistance, including the use of γ-H2AX and comet assays to monitor DNA damage and repair capacity as well as the use of clonogenic and β-galactosidase staining assays to assess long-term cell fate after DNA-damaging treatment. Finally, we also present examples of these methods currently used in our laboratory for studying the role of FOXM1 in DNA damage-induced senescence and epirubicin resistance.
The original version of this chapter was revised. The erratum to this chapter is available at: DOI 10.1007/978-1-4939-3347-1_18
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-1-4939-3347-1_18
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cheung-Ong K, Giaever G, Nislow C (2013) DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol 20:648–659
Podhorecka M, Skladanowski A, Bozko P (2010) H2AX phosphorylation: its role in DNA damage response and cancer therapy. J Nucleic Acids 2010
d'Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8:512–522
Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24:2463–2479
Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes AR, Yague E, Monteiro LJ, Kongsema M, Zona S, Man EP, Tsang JW, Coombes RC, Wu KJ, Khoo US, Medema RH, Freire R, Lam EW (2014) FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene 33:4144–4155
Monteiro LJ, Khongkow P, Kongsema M, Morris JR, Man C, Weekes D, Koo CY, Gomes AR, Pinto PH, Varghese V, Kenny LM, Charles Coombes R, Freire R, Medema RH, Lam EWF (2013) The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment. Oncogene 32:4634–4645
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
Jucha A, Wegierek-Ciuk A, Koza Z, Lisowska H, Wojcik A, Wojewodzka M, Lankoff A (2010) FociCounter: a freely available PC programme for quantitative and qualitative analysis of gamma-H2AX foci. Mutat Res 696:16–20
Carpenter A, Jones T, Lamprecht M, Clarke C, Kang I, Friman O, Guertin D, Chang J, Lindquist R, Moffat J, Golland P, Sabatini D (2006) Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7:R100
Liao W, McNutt MA, Zhu W-G (2009) The comet assay: a sensitive method for detecting DNA damage in individual cells. Methods 48:46–53
Spanswick V, Hartley J, Hartley J (2010) Measurement of DNA interstrand crosslinking in individual cells using the single cell gel electrophoresis (Comet) assay. In: Fox KR (ed) Drug-DNA interaction protocols, vol 613, Methods in molecular biology. Humana Press, New York, NY, pp 267–282. doi:10.1007/978-1-60327-418-0_17
Clingen P, Lowe J, Green ML (2000) Measurement of DNA damage and repair capacity as a function of age using the comet assay. In: Barnett Y, Barnett C (eds) Aging methods and protocols, vol 38, Methods in molecular medicine. Humana Press, New York, NY, pp 143–157. doi:10.1385/1-59259-070-5:143
Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2014) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886–895
Sharma A, Singh K, Almasan A (2012) Histone H2AX phosphorylation: a marker for DNA damage. In: Bjergbæk L (ed) DNA repair protocols, vol 920, Methods in molecular biology. Humana Press, New York, NY, pp 613–626. doi:10.1007/978-1-61779-998-3_40
Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315–2319
Munshi A, Hobbs M, Meyn R (2005) Clonogenic cell survival assay. In: Blumenthal R (ed) Chemosensitivity, vol 110, Methods in molecular medicine™. Humana Press, New York, NY, pp 21–28. doi:10.1385/1-59259-869-2:021
Plumb J (2004) Cell sensitivity assays: clonogenic assay. In: Langdon S (ed) Cancer cell culture, vol 88, Methods in molecular medicine™. Humana Press, New York, NY, pp 159–164. doi:10.1385/1-59259-406-9:159
Campisi J (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11:S27–S31
Kurz DJ, Decary S, Hong Y, Erusalimsky JD (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113(Pt 20):3613–3622
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92:9363–9367
Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O (2009) Protocols to detect senescence-associated beta-galactosidase (SA-[beta]gal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4:1798–1806
Itahana K, Itahana Y, Dimri GP (2013) Colorimetric detection of senescence-associated beta galactosidase. Methods Mol Biol 965:143–15623
Burn SF (2012) Detection of β-galactosidase activity: X-gal staining. Methods Mol Biol 886:241–250
Sun HW, Feigal RJ, Messer HH (1990) Cytotoxicity of glutaraldehyde and formaldehyde in relation to time of exposure and concentration. Pediatr Dent 12:303–307
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Khongkow, P. et al. (2016). In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs. In: Rueff, J., Rodrigues, A. (eds) Cancer Drug Resistance. Methods in Molecular Biology, vol 1395. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3347-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3347-1_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3345-7
Online ISBN: 978-1-4939-3347-1
eBook Packages: Springer Protocols